Basics Humacyte, Inc. Common Stock IPO Date: November 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $323.98M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.85% Avg Daily Range (30 D): $0.08 | 4.27% Avg Daily Range (90 D): $0.07 | 3.60% Institutional Daily Volume Avg Daily Volume: 1.6M Avg Daily Volume (30 D): 5.78M Avg Daily Volume (90 D): 4.49M Trade Size Avg Trade Size (Sh.): 181 Avg Trade Size (Sh.) (30 D): 367 Avg Trade Size (Sh.) (90 D): 317 Institutional Trades Total Inst.Trades: 302 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $3.95M Avg Inst. Trade (90 D): $2.04M Avg Inst. Trade Volume: .33M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.58M Avg Closing Trade (30 D): $7.51M Avg Closing Trade (90 D): $3.16M Avg Closing Volume: 333.72K     News Sep 18, 2025 @ 7:08 PM Russell 2000 Hits All-Time Highs: 8 Stocks Power S... Source: Piero Cingari Aug 11, 2025 @ 11:20 AM Humacyte Posts Q2 Revenue Miss Source: Jesterai Mar 26, 2025 @ 10:18 AM US Stocks Likely To Open Lower After 3-Day Advance... Source: Rishabh Mishra Jan 21, 2025 @ 3:44 PM DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The ... Source: The Law Offices Of Frank R. Cruz Jan 17, 2025 @ 5:28 PM HUMA Investors Have Opportunity to Lead Humacyte, ... Source: Business Wire Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.24 $.28 $-.16 Diluted EPS $-.24 $.28 $-.16 Revenue $ .3M $ .52M $ M Gross Profit $ .09M $ .37M $ Net Income / Loss $ -37.66M $ 39.14M $ -20.94M Operating Income / Loss $ -29.73M $ -23.18M $ -28.09M Cost of Revenue $ .21M $ .15M $ Net Cash Flow $ -24.82M $ 17.91M $ 24.37M PE Ratio